Dr. Paul BRADFIELD
Angestellt, CEO, Co-Founder, MesenFlow Technologies
Abschluss: Executive MBA, École Polytechnique Fédérale de Lausanne
Geneva, Schweiz
Werdegang
Berufserfahrung von Paul BRADFIELD
Bis heute 10 Jahre und 1 Monat, seit Juni 2014
CEO, Co-Founder
MesenFlow Technologies
•Chief Operations & Business Development – A commercial bio-imaging platform service •Strategic Analysis & Market Research – Impact of translational in-vitro technologies in cosmetic and drug development •Oncology & Chronic Inflammation – Target discovery, development of translational medicine models •Financial & Operational Planning – Forecasts, throughput & budgetary due-diligence, risk analyses •MassChallenge Business Finalist 2016 ‘Top 10%’
2 Jahre, Juni 2014 - Mai 2016
Scientific Collaborator
University of Geneva, Swizerland
•Disease Modeling & Assay Development •Project Management & External Collaborations •Established new in-vitro/in-vivo technologies to study disease pathways in oncology & inflammation
10 Monate, Aug. 2013 - Mai 2014
Consultant
Independent
•Excel Modeling & Quantitative Drug Development Algorithms •Translational Medicine –Proprietary technology, support drug development in clinical medicine • Professional Proofreading of scientific documents & peer-reviewed articles • Business Intelligence – Collation of data, provision of analysis reports
Drug Discovery Project Team Leader: Biologic drug to treat inflammatory disease •Member of an International Joint Steering Committee (JSC) •Successful Delivery of Multiple Milestones - From concept to preclinical •Development & Management of a Bio-imaging Platform – Responsible for SOP, GLP validations •Team member & collaborator in development teams & programs
6 Jahre und 6 Monate, Jan. 2002 - Juni 2008
Scientific Collaborator
University of Geneva
• Funded by Novartis Travelling Scientist Award • Construction, supervision and management of the flow assay and bio-imaging facility • Sabbatical period (2006) – Harvard Medical School, Boston, USA. • Successful research portfolio – multiple publication in high quality peer reviewed journals
4 Jahre und 11 Monate, Feb. 1997 - Dez. 2001
Research Associate & PhD Student
Univerisity of Birmingham
• Completion of PhD in Rheumatology • Development of leukocyte-stromal cell retention translational models in chronic inflammation • Establishment of a cell bank for primary human fibroblast cell lines – now a recognized global repository
Ausbildung von Paul BRADFIELD
1 Jahr und 5 Monate, Aug. 2013 - Dez. 2014
Business Administration
École Polytechnique Fédérale de Lausanne
New Venture Strategy, Business Model, Business Plan, Finance, Marketing & Legal - IP - Strategic Alliances, Partnership & Outsourcing - Sales Management - International Negotiations, Business in China
3 Jahre und 9 Monate, Apr. 1998 - Dez. 2001
Rheumatology
The University of Birmingham
Sprachen
Englisch
Muttersprache
Französisch
Gut